• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » NIMH’s Francis McMahon awarded Colvin Prize

NIMH’s Francis McMahon awarded Colvin Prize

November 2, 2016
CenterWatch Staff

The National Institute of Mental Health (NIMH) has announced that Francis McMahon, M.D., has been named a recipient of the Brain & Behavior Research Foundation’s 2016 Colvin Prize for Outstanding Achievement in Mood Disorders Research. Dr. McMahon is chief of the Human Genetics Branch at NIMH. He came to the Institute in 2002 to establish a new genetics unit within the Intramural Research Program. Dr. McMahon’s mission at NIMH has been the identification of genes that contribute to the risk for mood and anxiety disorders so that better methods of diagnosis and treatment can be developed.

In addition to Dr. McMahon, NIMH grantees Thomas Schulze, M.D., and Pamela Sklar, M.D., have been named recipients of this year’s Colvin Prize.

Thomas Schulze, M.D., is director of the Institute of Psychiatric Phenomics and Genomics at the University of Munich and is a former NIMH fellow. His research focuses on the genotype-phenotype relationship in psychiatric disorders. Dr. Schulze coordinates a Germany-wide center grant on longitudinal psychosis research and spearheads an international study on the genetic basis of response to lithium treatment in bipolar disorder.

Pamela Sklar, M.D., is chief of the Division of Psychiatric Genomics at the Icahn School of Medicine at Mount Sinai. As a neuroscientist, human geneticist, and clinical psychiatrist, Dr. Sklar investigates the genetic causes of psychiatric disorders, including schizophrenia and bipolar disorder. A major focus of her work has been to identify susceptibility genes for psychiatric diseases by applying tools developed for understanding and characterizing human sequence variation.

NIMH congratulates two other grantees, Vikram Patel, Ph.D., F. Med. Sci., and Charles Reynolds, III, M.D., named as recipients of the Brain & Behavioral Research Foundation’s 2016 Pardes Humanitarian Prize in Mental Health.

Dr. Patel is co-founder of Sangath, a non-government organization in Goa, India. Sangath has pioneered the training of lay people to deliver health care treatments and interventions to their communities. Dr. Patel has focused on the void in mental health care in developing countries, in particular, the shortage of psychologists and psychiatrists.

Dr. Reynolds is a professor of psychiatry, neurology, behavioral and community health sciences, clinical and translational science, and geriatric psychiatry at the University of Pittsburgh School of Medicine. Dr. Reynolds and his colleagues have made groundbreaking contributions to the prevention and treatment of depression in older adults. Dr. Reynolds leads an NIMH study with the Goa Medical College/India and with Sangath to develop and test a scalable model of depression prevention.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing